Cardiac Resynchronization Therapy Systems Market Estimated to Accumulate More Than US $4.8 Bn by the End of 2025
The World Health Organization (WHO) has rated cardiovascular diseases as the number one cause of death across the World, claiming more than a dozen of million casualty each year. Thankfully, the advent of cardiac resynchronization therapy systems are here, functioning as implantable medical devices that are adequate at resynchronizing contraction within the ventricles of heart. They achieve so by transferring small electrical impulses to the heart's muscle, helping it in pumping blood more efficiently. According to a recent business publication...
View full press release